guest ::
| Home > Publications Database > Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference. > print |
| Home > Publications Database > Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference. > print |
| 001 | 278915 | ||
| 005 | 20250605100736.0 | ||
| 024 | 7 | _ | |a 10.1002/alz.70078 |2 doi |
| 024 | 7 | _ | |a pmid:40437880 |2 pmid |
| 024 | 7 | _ | |a 1552-5260 |2 ISSN |
| 024 | 7 | _ | |a 1552-5279 |2 ISSN |
| 037 | _ | _ | |a DZNE-2025-00641 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Frost, Bess |b 0 |
| 245 | _ | _ | |a Insights into pathophysiology, biomarkers, and therapeutics in tauopathies: Proceedings of the Tau2024 Global Conference. |
| 260 | _ | _ | |a Hoboken, NJ |c 2025 |b Wiley |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1749039894_19982 |2 PUB:(DE-HGF) |x Review Article |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Recent years have seen major advances in tau-associated brain disorders through interdisciplinary research spanning molecular biology, neuroimaging, clinical trials, and therapeutic development. The Tau2024 Global Conference, hosted by the Alzheimer's Association, CurePSP, and Rainwater Charitable Foundation, showcased these efforts by bringing together researchers and experts worldwide to discuss the latest advancements in tau research. The conference aimed to attract talent and funding to study tauopathies, particularly among early-career researchers, and to foster interdisciplinary alignment and collaboration around challenges in tau research. In this manuscript, we summarize proceedings of the Tau2024 Global Conference, covering a wide range of topics, including lived experiences of individuals with genetic forms of tauopathies, global perspectives on tauopathies, and molecular mechanisms, brain microenvironments, biomarker developments, clinical trials, and therapeutic approaches to tauopathies. Through international, collaborative efforts, innovative research, and a commitment to inclusivity, researchers worldwide have demonstrated transformative breakthroughs toward diagnosing, treating, and, ultimately, preventing tau-related diseases. HIGHLIGHTS: The Tau2024 Global Conference presented updates and advances in tau research. Blood-based biomarkers offer specificity and longitudinal monitoring capabilities. There are a range of targetable mechanisms in the cascade of pathogenesis. International collaboration is vital to address disparities in tauopathies. |
| 536 | _ | _ | |a 352 - Disease Mechanisms (POF4-352) |0 G:(DE-HGF)POF4-352 |c POF4-352 |f POF IV |x 0 |
| 536 | _ | _ | |a 353 - Clinical and Health Care Research (POF4-353) |0 G:(DE-HGF)POF4-353 |c POF4-353 |f POF IV |x 1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 650 | _ | 7 | |a Alzheimer's disease |2 Other |
| 650 | _ | 7 | |a neurodegenerative disease |2 Other |
| 650 | _ | 7 | |a tau disorder |2 Other |
| 650 | _ | 7 | |a tau protein |2 Other |
| 650 | _ | 7 | |a tauopathies |2 Other |
| 650 | _ | 7 | |a Biomarkers |2 NLM Chemicals |
| 650 | _ | 7 | |a tau Proteins |2 NLM Chemicals |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: therapy |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: physiopathology |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: diagnosis |2 MeSH |
| 650 | _ | 2 | |a Tauopathies: genetics |2 MeSH |
| 650 | _ | 2 | |a Biomarkers: metabolism |2 MeSH |
| 650 | _ | 2 | |a Congresses as Topic |2 MeSH |
| 650 | _ | 2 | |a tau Proteins: metabolism |2 MeSH |
| 650 | _ | 2 | |a Brain: pathology |2 MeSH |
| 650 | _ | 2 | |a Brain: metabolism |2 MeSH |
| 700 | 1 | _ | |a Rowe, James B |b 1 |
| 700 | 1 | _ | |a Akinyemi, Rufus O |b 2 |
| 700 | 1 | _ | |a Abisambra, Jose F |b 3 |
| 700 | 1 | _ | |a Ashton, Nicholas J |b 4 |
| 700 | 1 | _ | |a Brendel, Matthias |0 P:(DE-2719)9001539 |b 5 |u dzne |
| 700 | 1 | _ | |a Buée, Luc |b 6 |
| 700 | 1 | _ | |a Butler, David |b 7 |
| 700 | 1 | _ | |a Carrillo, Maria C |b 8 |
| 700 | 1 | _ | |a Chung, Peter |b 9 |
| 700 | 1 | _ | |a Clelland, Claire D |b 10 |
| 700 | 1 | _ | |a DeVos, Sarah L |b 11 |
| 700 | 1 | _ | |a Diaz, Kristophe |b 12 |
| 700 | 1 | _ | |a Edelmayer, Rebecca M |b 13 |
| 700 | 1 | _ | |a Elahi, Fanny M |b 14 |
| 700 | 1 | _ | |a Ellajosyula, Ratnavalli |b 15 |
| 700 | 1 | _ | |a Ewen, Colin |b 16 |
| 700 | 1 | _ | |a Fontana, Igor Camargo |b 17 |
| 700 | 1 | _ | |a Galas, Marie-Christine |b 18 |
| 700 | 1 | _ | |a Hansson, Oskar |b 19 |
| 700 | 1 | _ | |a Höglinger, Günter |0 P:(DE-2719)2811373 |b 20 |u dzne |
| 700 | 1 | _ | |a Horie, Kanta |b 21 |
| 700 | 1 | _ | |a Ibanez, Agustín |b 22 |
| 700 | 1 | _ | |a Jacobs, Linde |b 23 |
| 700 | 1 | _ | |a Maina, Mahmoud B |b 24 |
| 700 | 1 | _ | |a Malpetti, Maura |b 25 |
| 700 | 1 | _ | |a McDade, Eric |b 26 |
| 700 | 1 | _ | |a McEwan, Will |b 27 |
| 700 | 1 | _ | |a Montoliu-Gaya, Laia |b 28 |
| 700 | 1 | _ | |a Mummery, Catherine J |b 29 |
| 700 | 1 | _ | |a Orr, Miranda E |b 30 |
| 700 | 1 | _ | |a Rohrer, Jonathan D |b 31 |
| 700 | 1 | _ | |a Rommel, Amy |b 32 |
| 700 | 1 | _ | |a Sastre, Carlos |b 33 |
| 700 | 1 | _ | |a Spires-Jones, Tara L |b 34 |
| 700 | 1 | _ | |a Tee, Boon Lead |b 35 |
| 700 | 1 | _ | |a Viney, Tim J |b 36 |
| 700 | 1 | _ | |a Walker, Jamie M |b 37 |
| 700 | 1 | _ | |a Wegmann, Susanne |0 P:(DE-2719)2812695 |b 38 |u dzne |
| 700 | 1 | _ | |a Wildsmith, Kristin |b 39 |
| 700 | 1 | _ | |a Yadav, Ravi |b 40 |
| 700 | 1 | _ | |a Mahinrad, Simin |0 0000-0002-5927-7130 |b 41 |
| 700 | 1 | _ | |a Sexton, Claire |0 0000-0002-3846-2986 |b 42 |
| 773 | _ | _ | |a 10.1002/alz.70078 |g Vol. 21, no. 5, p. e70078 |0 PERI:(DE-600)2201940-6 |n 5 |p e70078 |t Alzheimer's and dementia |v 21 |y 2025 |x 1552-5260 |
| 856 | 4 | _ | |u https://pub.dzne.de/record/278915/files/DZNE-2025-00641%20SUP.pdf |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/278915/files/DZNE-2025-00641.pdf |
| 856 | 4 | _ | |x pdfa |u https://pub.dzne.de/record/278915/files/DZNE-2025-00641%20SUP.pdf?subformat=pdfa |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/278915/files/DZNE-2025-00641.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:278915 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)9001539 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 20 |6 P:(DE-2719)2811373 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 38 |6 P:(DE-2719)2812695 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-352 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Disease Mechanisms |x 0 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-353 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 1 |
| 914 | 1 | _ | |y 2025 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2025-01-06 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ALZHEIMERS DEMENT : 2022 |d 2025-01-06 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2025-01-06 |w ger |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2025-01-06 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b ALZHEIMERS DEMENT : 2022 |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2025-01-06 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2025-01-06 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2025-01-06 |
| 920 | 1 | _ | |0 I:(DE-2719)1110007 |k AG Haass |l Molecular Neurodegeneration |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1111015 |k Clinical Research (Munich) |l Clinical Research (Munich) |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1810006 |k AG Wegmann |l Protein Actions in Neurodegeneration |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1110007 |
| 980 | _ | _ | |a I:(DE-2719)1111015 |
| 980 | _ | _ | |a I:(DE-2719)1810006 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|